Patients with stage 3 colorectal cancer who tested MRD-positive with Signatera after surgery saw a meaningful survival benefit from Celebrex plus chemotherapy. The FDA granted fast track status to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results